This Article Full Text Full Text (PDF) CME: Take the course for this article: Circulation: March 18, 2008, Volume 117, Number 11 Data Supplement Correction (v120,pe71) All Versions of this Article: 117/11/1397    most recent CIRCULATIONAHA.107.727271v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dowson, A. Articles by Rickards, A. Search for Related Content PubMed PubMed Citation Articles by Dowson, A. Articles by Rickards, A. Pubmed/NCBI databases Medline Plus Health Information Headache Migraine Related Collections Other Ethics and Policy Primary prevention Other Treatment Echocardiography CV surgery: other Pediatric and congenital heart disease, including cardiovascular surgery Related Article

(Circulation. 2008;117:1397-1404.)
© 2008 American Heart Association, Inc.

Interventional Cardiology

Migraine Intervention With STARFlex Technology (MIST) Trial

A Prospective, Multicenter, Double-Blind, Sham-Controlled Trial to Evaluate the Effectiveness of Patent Foramen Ovale Closure With STARFlex Septal Repair Implant to Resolve Refractory Migraine Headache

Andrew Dowson, MBBS, PhD; Michael J. Mullen, MBBS, MRCP, MD; Richard Peatfield, MD, FRCP; Keith Muir, MD, FRCP; Arif Anis Khan, MBBS, FCPS; Christopher Wells, MB, ChB, FRCA; Susan L. Lipscombe, MB, ChB, MRCP; Trevor Rees, MB, ChB; Joseph V. De Giovanni, MD, FRCP, FRCPCH, MOM; W. Lindsay Morrison, MD, FRCP; David Hildick-Smith, MD, FRCP; Giles Elrington, MD; W. Stewart Hillis, MB, ChB, FRCP, FRCS; Iqbal S. Malik, MA, MRCP, PhD; Anthony Rickards, MBBS, FRCP, FESC

From Kings College Hospital, London (A.D.); Royal Brompton Hospital, London (M.J.M., A.A.K, A.R); Princess Margaret Migraine Clinic Charing Cross Hospital, London (R.P.); Division of Clinical Neurosciences, University of Glasgow, Glasgow (K.M); Pain Research Institute, Liverpool (C.W.); Brighton and Sussex University Hospitals NHS Trust, Brighton (D.H.-S., S.L.L.); Hawthorn Surgery, Sutton Coldfield (T.R.); University Hospital, Birmingham (J.V.D.G.); Cardiothoracic Centre, Liverpool (W.L.M.); Barts and the London NHS Trust, London (G.E.); Western Infirmary, Glasgow (W.S.H.); and St Mary’s Hospital, London (I.S.M.), UK.

Correspondence to Dr Andrew J. Dowson, The King’s Headache Service, King’s College Hospital, Denmark Hill, London SE5 9RS, UK. E-mail dr.dowson{at}btopenworld.com

Received July 12, 2007; accepted December 6, 2007.

Background— Patent foramen ovale (PFO) is prevalent in patients with migraine with aura. Observational studies show that PFO closure resulted in migraine cessation or improvement in 80% of such patients. We investigated the effects of PFO closure for migraine in a randomized, double-blind, sham-controlled trial.

Methods and Results— Patients who suffered from migraine with aura, experienced frequent migraine attacks, had previously failed 2 classes of prophylactic treatments, and had moderate or large right-to-left shunts consistent with the presence of a PFO were randomized to transcatheter PFO closure with the STARFlex implant or to a sham procedure. Patients were followed up for 6 months. The primary efficacy end point was cessation of migraine headache 91 to 180 days after the procedure. In total, 163 of 432 patients (38%) had right-to-left shunts consistent with a moderate or large PFO. One hundred forty-seven patients were randomized. No significant difference was observed in the primary end point of migraine headache cessation between implant and sham groups (3 of 74 versus 3 of 73, respectively; P=0.51). Secondary end points also were not achieved. On exploratory analysis, excluding 2 outliers, the implant group demonstrated a greater reduction in total migraine headache days (P=0.027). As expected, the implant arm experienced more procedural serious adverse events. All events were transient.

Conclusions— This trial confirmed the high prevalence of right-to-left shunts in patients with migraine with aura. Although no significant effect was found for primary or secondary end points, the exploratory analysis supports further investigation. The robust design of this study has served as the model for larger trials that are currently underway in the United States and Europe.

---

 

CLINICAL PERSPECTIVE

Related Article:

Clinical Summaries
Circulation 2008 117: 1353. [Extract] [Full Text]

This article has been cited by other articles:

				J-J Guex Complications and side-effects of foam sclerotherapy Phlebology, December 1, 2009; 24(6): 270 - 274. [Abstract] [Full Text] [PDF]

				I. Monte, S. Grasso, S. Licciardi, and L. P. Badano Head-to-head comparison of real-time three-dimensional transthoracic echocardiography with transthoracic and transesophageal two-dimensional contrast echocardiography for the detection of patent foramen ovale Eur J Echocardiogr, November 28, 2009; (2009) jep195v1. [Abstract] [Full Text] [PDF]

				M. Reisman and C. J. Fuller Is patent foramen ovale closure indicated for migraine?: Patent Foramen Ovale Closure for Migraine Circ Cardiovasc Interv, October 1, 2009; 2(5): 468 - 474. [Full Text] [PDF]

				J. D. Carroll and E. P. Carroll Is patent foramen ovale closure indicated for migraine?: PFO Closure Is Not Indicated for Migraine: "Don't Shoot First, Ask Questions Later" Circ Cardiovasc Interv, October 1, 2009; 2(5): 475 - 481. [Full Text] [PDF]

				H. Marcovitch Libel law in the UK BMJ, July 9, 2009; 339(jul08_4): b2759 - b2759. [Full Text]

				M Belton and K. Gyi Improvement in pulmonary function following closure of a patent foramen ovale in a man with cystic fibrosis J R Soc Med, July 1, 2009; 102(Supplement_1): 59 - 62. [Full Text] [PDF]

				S. R. Dixon, C. L. Grines, and W. W. O'Neill The year in interventional cardiology. J. Am. Coll. Cardiol., June 2, 2009; 53(22): 2080 - 2097. [Full Text] [PDF]

				J-L Gillet, J M Guedes, J-J Guex, C Hamel-Desnos, M Schadeck, M Lauseker, and F A Allaert Side-effects and complications of foam sclerotherapy of the great and small saphenous veins: a controlled multicentre prospective study including 1025 patients Phlebology, June 1, 2009; 24(3): 131 - 138. [Abstract] [Full Text] [PDF]

				J. T. Jesurum, C. J. Fuller, J. Renz, K. A. Krabill, M. P. Spencer, and M. Reisman Diagnosis of Secondary Source of Right-to-Left Shunt With Balloon Occlusion of Patent Foramen Ovale and Power M-Mode Transcranial Doppler J. Am. Coll. Cardiol. Intv., June 1, 2009; 2(6): 561 - 567. [Abstract] [Full Text] [PDF]

				J. H. Rogers and T. W. Smith Eliminating Right-to-Left Shunt With Patent Foramen Ovale Closure: Not as Simple as it Seems J. Am. Coll. Cardiol. Intv., June 1, 2009; 2(6): 568 - 569. [Full Text] [PDF]

				A. May Morphing voxels: the hype around structural imaging of headache patients Brain, June 1, 2009; 132(6): 1419 - 1425. [Abstract] [Full Text] [PDF]

				A. E. Weyman The year in echocardiography. J. Am. Coll. Cardiol., April 28, 2009; 53(17): 1558 - 1567. [Full Text] [PDF]

				B. Meier Stroke and migraine: a cardiologist's headache Heart, April 1, 2009; 95(7): 595 - 602. [Full Text] [PDF]

				M. C. Johansson, M. Dellborg, and P. Eriksson Letter by Johansson et al Regarding Article, "Migraine Intervention With STARFlex Technology (MIST) Trial" Circulation, February 10, 2009; 119(5): e193 - e193. [Full Text] [PDF]

				A. Dowson, M. J. Mullen, A. A. Khan, A. Rickards, R. Peatfield, K. Muir, C. Wells, S. L. Lipscombe, D. Hildick-Smith, T. Rees, et al. Response to Letter Regarding Article, "Migraine Intervention With STARFlex Technology (MIST) Trial" Circulation, February 10, 2009; 119(5): e194 - e194. [Full Text] [PDF]

				K N Asrress and A R J Mitchell Intracardiac echocardiography Heart, February 1, 2009; 95(4): 327 - 331. [Abstract] [Full Text] [PDF]

				C. Vigna, N. Marchese, V. Inchingolo, G. M. Giannatempo, M. A. Pacilli, P. Di Viesti, M. Impagliatelli, R. Natali, A. Russo, R. Fanelli, et al. Improvement of Migraine After Patent Foramen Ovale Percutaneous Closure in Patients With Subclinical Brain Lesions: A Case-Control Study J. Am. Coll. Cardiol. Intv., February 1, 2009; 2(2): 107 - 113. [Abstract] [Full Text] [PDF]

				P. Wilmshurst The Effect of Persistent Foramen Ovale Closure on Migraine Remains an Enigma J. Am. Coll. Cardiol. Intv., February 1, 2009; 2(2): 114 - 115. [Full Text] [PDF]

				A Wahl and B Meier Patent foramen ovale and ventricular septal defect closure Heart, January 1, 2009; 95(1): 70 - 82. [Abstract] [Full Text] [PDF]

				S. R. Messe and S. E. Kasner Patent Foramen Ovale in Cryptogenic Stroke: Not to Close Circulation, November 4, 2008; 118(19): 1999 - 2004. [Full Text] [PDF]

				T. Kurth, C. Tzourio, and M.-G. Bousser Migraine: A Matter of the Heart? Circulation, September 30, 2008; 118(14): 1405 - 1407. [Full Text] [PDF]

				T. Rundek, M. S.V. Elkind, M. R. Di Tullio, E. Carrera, Z. Jin, R. L. Sacco, and S. Homma Patent Foramen Ovale and Migraine: A Cross-Sectional Study From the Northern Manhattan Study (NOMAS) Circulation, September 30, 2008; 118(14): 1419 - 1424. [Abstract] [Full Text] [PDF]

				D. Hildick-Smith, M. Behan, P. Haworth, B. Rana, and M. Thomas Patent Foramen Ovale Closure Without Echocardiographic Control: Use of "Standby" Intracardiac Ultrasound J. Am. Coll. Cardiol. Intv., August 1, 2008; 1(4): 387 - 391. [Abstract] [Full Text] [PDF]

				Closure of Patent Foramen Ovale for Migraine Relief: A Study Headache Journal Watch Cardiology, March 26, 2008; 2008(326): 1 - 1. [Full Text]

				J. D. Carroll Migraine Intervention With STARFlex Technology Trial: A Controversial Trial of Migraine and Patent Foramen Ovale Closure Circulation, March 18, 2008; 117(11): 1358 - 1360. [Full Text] [PDF]